News and Events

Hatchtech Announces Successful Phase 3 Results

2/09/2014 | Press Releases

2nd September 2014 Melbourne, Australia

Specialty pharmaceutical company Hatchtech Pty Ltd today announced successful completion of its two pivotal Phase 3 clinical studies evaluating Xeglyze Lotion (formerly DeOvo Lotion) as a potential treatment for head lice infestation.


Categories